Atlas Trials

A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia, Cognition, and Hip Function Recovery in Patients Undergoing Hip Arthroplasty

Clinical trial NCT06520306 · UNKNOWN

Trial details

NCT number
NCT06520306
Sponsor
Wang wanxia
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Femoral Neck Disease
Start date
2024-03-15
Primary completion
2024-08-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.